R&H Clinical Research, Inc.

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Chronic kidney disease1 trial
• Lung cancer1 trial
• Sjögren's disease1 trial
• Type 2 diabetes1 trial

Phase

• Phase 23 trials
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Regeneron Pharmaceuticals2 trials
• Delfi Diagnostics Inc.1 trial
• Ionis Pharmaceuticals, Inc.1 trial
• Vor Biopharma1 trial

Running trials

• Recruiting

  Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

  NCT07404865· Phase 3· Vor Biopharma· Source

  Contact: Jeremy Sokolove

• Recruiting

  Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  NCT07271186· Phase 2· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Active, not recruiting

  A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

  NCT05519475· Phase 2· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung

  NCT05306288· Delfi Diagnostics Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Sjögren's disease1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224

  NCT04932512· Phase 2· Ionis Pharmaceuticals, Inc.· Source